Literature DB >> 12551989

Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.

Takafumi Nakamura1, Kenzo Sato, Hirofumi Hamada.   

Abstract

The initial recognition and binding of adenovirus vector to the host cell surface is mediated by interaction between the adenovirus fiber knob protein and its receptor, the coxsackievirus and adenovirus receptor (CAR). This natural tropism of adenovirus vector needs to be ablated in order to achieve targeted gene transfer. To this end, we noted that adenovirus serotype 40 (Ad40) contains two distinct long and short fibers; the short fiber is unable to recognize CAR, while the long fiber binds CAR. We generated adenovirus serotype 5-based mutants with chimeric Ad40-derived fibers, which were composed of either long or short shafts together with CAR binding or nonbinding knobs. The capacity of these adenovirus mutants for in vitro and in vivo gene transfer to liver cells was examined. In the case of primary human hepatocytes displaying a high expression level of CAR and alphav integrin, both CAR binding ability and fiber shaft length played important roles in efficient transduction. Most significantly, the high transduction efficiency observed in the liver and spleen following intravenous administration of adenovirus vector was dramatically reduced by both ablation of fiber-CAR interaction and the use of replaceable short fiber. In other tissues displaying a low level of transduction, no significant differences in transduction efficiency were observed among adenovirus vector mutants. Furthermore, incorporation of a 7-lysine-residue motif at the C-terminal end of CAR-nonbinding short fiber efficiently achieved transduction of target cells via the heparan-containing receptor. Our results demonstrated that the natural tropism of adenovirus in vivo is influenced not only by fiber-CAR interaction but also by fiber shaft length. Furthermore, our strategy may be useful for retargeting adenovirus to particular tumors and tissue types with specific receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551989      PMCID: PMC141073          DOI: 10.1128/jvi.77.4.2512-2521.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo.

Authors:  P N Reynolds; S A Nicklin; L Kaliberova; B G Boatman; W E Grizzle; I V Balyasnikova; A H Baker; S M Danilov; D T Curiel
Journal:  Nat Biotechnol       Date:  2001-09       Impact factor: 54.908

4.  CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.

Authors:  R Alemany; D T Curiel
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

5.  Targeted gene delivery by tropism-modified adenoviral vectors.

Authors:  J T Douglas; B E Rogers; M E Rosenfeld; S I Michael; M Feng; D T Curiel
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

6.  Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.

Authors:  D Rajotte; W Arap; M Hagedorn; E Koivunen; R Pasqualini; E Ruoslahti
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

7.  A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells.

Authors:  H Stecher; D M Shayakhmetov; G Stamatoyannopoulos; A Lieber
Journal:  Mol Ther       Date:  2001-07       Impact factor: 11.454

8.  Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.

Authors:  Takafumi Nakamura; Kenzo Sato; Hirofumi Hamada
Journal:  Hum Gene Ther       Date:  2002-03-20       Impact factor: 5.695

9.  Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.

Authors:  P Leissner; V Legrand; Y Schlesinger; D A Hadji; M van Raaij; S Cusack; A Pavirani; M Mehtali
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

10.  Antigens and structure of the adenovirus.

Authors:  R C Valentine; H G Pereira
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

View more
  38 in total

1.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.

Authors:  Makoto Sato; Mai Johnson; Liqun Zhang; Baohui Zhang; Kim Le; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

3.  Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Shaoheng Ni; André Lieber
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop.

Authors:  J Woraratanadharm; S Rubinchik; H Yu; F Fan; S M Morrow; J Y Dong
Journal:  Gene Ther       Date:  2004-09       Impact factor: 5.250

5.  Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

6.  Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.

Authors:  Andrea Hesse; Daniela Kosmides; Roland E Kontermann; Dirk M Nettelbeck
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

7.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

8.  Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

Authors:  Anurag Sharma; Dinesh S Bangari; Manish Tandon; Aseem Pandey; Harm HogenEsch; Suresh K Mittal
Journal:  Virology       Date:  2009-02-10       Impact factor: 3.616

9.  Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.

Authors:  Elena A Kashentseva; Joanne T Douglas; Kurt R Zinn; David T Curiel; Igor P Dmitriev
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

10.  Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.

Authors:  Frederik H E Schagen; Harm C A Graat; Jan E Carette; Jort Vellinga; Michael A van Geer; Rob C Hoeben; Terence S Dermody; Victor W van Beusechem
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.